The current analyses were based on 111 patients attending the 6-week
follow-up, and 89 attended the 12-month follow-up. Baseline
characteristisc for the patients attending the 6-week and/or the
12-month follow-up, respectively, are showen in table 1.
Dropout-analysis conducted in the RCT, showed that the
patients in the current study were less likely to be overweitht (72.7%
vs. 85.5%, p=0.046) and physically inactive (32.0% vs. 46.7%,
p=0.042). Furthermore, respondents had a higher self-reported quality of
life score on the physical factors measured by the SF-36 (median: 58.8
vs. 50.6 among, p=0.042). Regarding the overall and the mental SF-36 score the respondents and the dropouts did not differ. Though not statistically
significant the proportion of underweight patients were higher among the
respondent (8,7% vs. 1.6, p=0.060).
The majority of the patients were men (65.8% and 65.2%), the median age was 53 and 55 years, respectively.
In the case of both the CPD and CO analyses, just more than half the
participants were male (234 of 421, 55.6% and 276 of 517, 53.4%,
respectively), the average age was 50 years in both groups, participants
had an average baseline salivary cotinine concentration of 368 and 360
ng/ml and an FTND of 5 and 6, respectively (Table 1). At 4-week
follow-up 240 of 421 (57.0%) participants were abstinent in the CPD
analysis and 289 of 517 (55.9%) in the CO analysis, and at 6-month
follow-up 100 of 421 (23.8%) in the CPD analysis and 118 of 517
(22.8%) in the CO analysis (Table 2).